GlassScriptPhysician profile
Anitha Nallu
NPI 1164530275
$1,266.05
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $517 · 2021: $250 · 2022: $39.75 · 2023: $32.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.73 · Education: $8.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.73 |
| Education | $8.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $270.05 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $210.70 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $162.78 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $133.02 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $99.96 | 2019 | |
| Fresenius USA Marketing, INC. | $73.82 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $70.31 | 2019-2020 | |
| Horizon Therapeutics Plc | $56.72 | 2019-2023 | Tepezza |
| Alnylam Pharmaceuticals INC. | $41.97 | 2021 | |
| Daiichi Sankyo INC. | $35.76 | 2020 | |
| Amgen INC. | $26.25 | 2020 | |
| Genzyme Corporation | $24.64 | 2022 | |
| Avion Pharmaceuticals | $21.33 | 2020 | |
| Amag Pharmaceuticals, INC. | $15.80 | 2021 | |
| Allergan, INC. | $14.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $8.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anitha Nallu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.